Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

596
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
596
Drug Therapy01:28

Drug Therapy

154
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
154
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

993
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
993
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

419
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
419
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

317
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
317

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026
Same author

Comprehensive Geriatric Assessment and Medication "Appropriateness".

The Senior care pharmacist·2026
Same author

Factors Associated with Healthcare Utilization in Children with Sickle Cell Disease in Saudi Arabia.

International journal of environmental research and public health·2026
Same author

Caring for the Caregiver.

The Senior care pharmacist·2026
Same author

Reflecting on the Value of Mentors.

The Senior care pharmacist·2026
Same author

Navigating the New F-605: Collaboration and Compliance in Psychotropic Medication Use.

The Senior care pharmacist·2025

Related Experiment Video

Updated: Nov 19, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359

Depression Part 3: Medication Related Problems.

Demetra Antimisiaris1, Brittany McHolan2, Daniela Moga3

  • 11University of Louisville, Schools of Public Health and Medicine, Louisville, Kentucky.

The Senior Care Pharmacist
|January 29, 2021
PubMed
Summary

Managing psychoactive medications in older adults requires balancing efficacy and toxicity. High medication load increases hospitalization risk, particularly with antidepressants used for depression.

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

983
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K

Related Experiment Videos

Last Updated: Nov 19, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

359
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

983
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.1K

Area of Science:

  • Geriatric Pharmacology
  • Psychiatry
  • Clinical Pharmacy

Background:

  • Older adults often have complex health needs requiring multiple medications.
  • Psychoactive medication use in the elderly is common for conditions like depression.
  • Polypharmacy in older populations increases the risk of adverse drug events and hospitalizations.

Purpose of the Study:

  • To highlight the importance of avoiding toxicity alongside efficacy when prescribing psychoactive drugs to older individuals.
  • To discuss medication-related problems associated with antidepressants in geriatric populations.
  • To provide considerations for safe management of psychoactive medications in the elderly.

Main Methods:

  • Review of existing literature on psychoactive medication use in older adults.
  • Analysis of the relationship between medication load and hospitalization rates.
  • Focus on the antidepressant pharmacological class for depression treatment in the elderly.

Main Results:

  • Higher psychoactive medication load is linked to increased all-cause hospitalization rates and risks.
  • Antidepressants are a key class of psychoactive drugs used for depression and comorbidities in older adults.
  • Specific considerations are needed to mitigate medication-related problems with antidepressants in this demographic.

Conclusions:

  • Balancing efficacy and toxicity is crucial for psychoactive medication management in older adults.
  • Reducing medication load can decrease hospitalization risks.
  • Careful selection and management of antidepressants are essential to avoid adverse events in the elderly.